@article{48658ee00a894b9db0e435d37ed273cd,
title = "About This Continuing Medical Education Activity",
author = "David Wyles and Sulkowski, {Mark S.} and Douglas Dieterich",
note = "Funding Information: Supplement sponsorship. This article appears as part of the supplement “Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.” This activity is accredited by the University of Cincinnati. This activity is provided by the Chronic Liver Disease Foundation. This activity is supported by an educational grant from Merck & Co. Funding Information: David Wyles, MD, is Associate Professor of Medicine in the Division of Infectious Diseases at the University of California San Diego, La Jolla, California. Dr Wyles has served as an advisor to AbbVie, Bristol-Myers Squibb, Gilead, Janssen, and Merck. Dr Wyles{\textquoteright}s institution has received grant support from AbbVie, Bristol-Myers Squibb, Gilead, Merck, and Tacere. Funding Information: Jennifer Kiser, PharmD, is Associate Professor in the Department of Pharmaceutical Sciences at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado. Dr Kiser{\textquoteright}s institution has received grant support from Janssen. Dr Kiser{\textquoteright}s spouse has served on the speaker{\textquoteright}s bureau for Astellas.",
year = "2016",
month = jul,
day = "1",
doi = "10.1093/cid/ciw218",
language = "English (US)",
volume = "63",
pages = "S1--S2",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
}